UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities and Exchange Act of 1934
Date of Report (Date of earliest reported event): June 30, 2004
GEOPHARMA, INC.
(Exact name of registrant as specified in charter)
| | | | |
| Florida | | 001-16185 | | 59-2600232 |
| (State or other jurisdiction of incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
| | |
| 6950 Bryan Dairy Road, Largo, Florida | | 33777 |
| (Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (727) 544-8866
ITEM 7. Financial Statements and Exhibits.
(c) Exhibits. The following documents are filed as exhibits to this report:
| | |
| 99.1 | | Press release issued June 30, 2004 |
ITEM 9. Regulation FD Disclosure (information furnished under Item 12, “Results of Operations and Financial Condition”).
The information contained in this Current Report is intended to be furnished under Item 12, “Results of Operations and Financial Condition,” and is provided under Item 9 pursuant to interim guidance issued by the Securities and Exchange Commission in Release Nos. 33-8216 and 34-47583. As such, the information hereunder shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
A copy of the press release issued by GeoPharma, Inc. on June 30, 2004, announcing its results of operations for the fiscal year ended March 31, 2004, is filed herewith as Exhibit 99.1 and is incorporated herein by reference.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | |
| | | GEOPHARMA, INC. |
| |
Date: July 01, 2004 | | /s/ Mihir K. Taneja
|
| | | Mihir K. Taneja, |
| | | Chief Executive Officer |
| |
| | | /s/ Carol Dore-Falcone
|
| | | Carol Dore-Falcone, |
| | | Vice President and Chief Financial Officer |
3
